359 related articles for article (PubMed ID: 16440585)
21. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX
FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
[TBL] [Abstract][Full Text] [Related]
22. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.
Sheikpranbabu S; Haribalaganesh R; Gurunathan S
Diabetes Metab; 2011 Dec; 37(6):505-11. PubMed ID: 21636306
[TBL] [Abstract][Full Text] [Related]
23. Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells.
Takamura Y; Tomomatsu T; Kubo E; Tsuzuki S; Akagi Y
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3216-23. PubMed ID: 18362110
[TBL] [Abstract][Full Text] [Related]
24. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
25. [Downregulation of the pigment epithelium derived factor by hypoxia and elevated glucose concentration in cultured human retinal pigment epithelial cells].
Yao Y; Guan M; Zhao XQ; Huang YF
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1989-92. PubMed ID: 14703436
[TBL] [Abstract][Full Text] [Related]
26. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
27. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
Jinnouchi Y; Yamagishi S; Matsui T; Takenaka K; Yoshida Y; Nakamura K; Ueda S; Imaizumi T
Brain Res; 2007 Sep; 1167():92-100. PubMed ID: 17692294
[TBL] [Abstract][Full Text] [Related]
28. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
[TBL] [Abstract][Full Text] [Related]
29. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
[TBL] [Abstract][Full Text] [Related]
31. Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy.
Yamagishi S; Amano S; Inagaki Y; Okamoto T; Koda Y; Soejima M; Kimura H
Int J Clin Pharmacol Res; 2002; 22(3-4):67-71. PubMed ID: 12837042
[TBL] [Abstract][Full Text] [Related]
32. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.
Cai J; Kehoe O; Smith GM; Hykin P; Boulton ME
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2163-71. PubMed ID: 18436850
[TBL] [Abstract][Full Text] [Related]
33. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy.
Shen X; Xie B; Cheng Y; Jiao Q; Zhong Y
Ocul Immunol Inflamm; 2011 Aug; 19(4):246-54. PubMed ID: 21770802
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Inoue H
Diabetes Metab Res Rev; 2009 Jan; 25(1):52-6. PubMed ID: 18677713
[TBL] [Abstract][Full Text] [Related]
35. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies of pigment epithelium-derived factor in human Schwann cells after treatment with axolemma-enriched fraction.
Lertsburapa T; De Vries GH
J Neurosci Res; 2004 Mar; 75(5):624-31. PubMed ID: 14991838
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
38. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
[TBL] [Abstract][Full Text] [Related]
39. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M; Makita Z
Biochem Biophys Res Commun; 2002 Aug; 296(4):877-82. PubMed ID: 12200129
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
